<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferases (GSTs) are a family of enzymes that play an important role in the prevention of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> by detoxifying numerous potentially carcinogenic compounds </plain></SENT>
<SENT sid="1" pm="."><plain>GSTs conjugate reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> to a variety of electrophilic and hydrophobic compounds, converting them into more soluble, more easily excretable compounds </plain></SENT>
<SENT sid="2" pm="."><plain>Decreased <z:chebi fb="0" ids="16856">glutathione</z:chebi> S-transferase-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> (GSTPI) enzyme activity has been reported in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and an inverse correlation was demonstrated between GST enzyme activity and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> incidence in the gastrointestinal tract, but the role of GSTPI <z:chebi fb="5" ids="33699">messengerRNA</z:chebi> (<z:chebi fb="2" ids="33699">mRNA</z:chebi>) expression in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and associated <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> is uncertain </plain></SENT>
<SENT sid="3" pm="."><plain>The purpose of this study was to investigate the role of GSTPI <z:chebi fb="2" ids="33699">mRNA</z:chebi> and protein expression in the development and progression of the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence, and to investigate the potential of GSTPI quantitation as a biomarker in the clinical management of this disease </plain></SENT>
<SENT sid="4" pm="."><plain>GSTPI <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression levels, in relation to the housekeeping gene beta-actin, were analyzed using a quantitative real-time reverse transcription-polymerase chain reaction method (TaqMan) in 111 specimens from 19 patients with <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> without <z:mp ids='MP_0002038'>carcinoma</z:mp> (BE group), 21 patients with Barrett's-associated <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (EA group), and a control group of 10 patients without evidence of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> or <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:hpo ids='HP_0002020'>gastroesophageal reflux disease</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>GSTPI <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was detectable in <z:hpo ids='HP_0000001'>all</z:hpo> 111 samples investigated </plain></SENT>
<SENT sid="6" pm="."><plain>Analyzed according to histopathologic group, the median GSTPI <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression was highest in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus epithelium, intermediate in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, and lowest in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues (P &lt; 0.001) </plain></SENT>
<SENT sid="7" pm="."><plain>The median GSTPI expression was significantly decreased in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> tissues compared to matching <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus from either the BE group (P = 0.001) or the EA group (P = 0.023) </plain></SENT>
<SENT sid="8" pm="."><plain>GSTPI expression levels in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues were decreased compared to matching <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues from the patients with <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (P = 0.011) </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, GSTPI <z:chebi fb="2" ids="33699">mRNA</z:chebi> expression values were significantly different between metaplastic, dysplastic, and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> tissues (P = 0.026) </plain></SENT>
<SENT sid="10" pm="."><plain>GSTPI expression levels were also significantly lower in histologically <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus tissues from patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (EA group) compared to both <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues from patients without <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (BE group; P = 0.007) and <z:mpath ids='MPATH_458'>normal</z:mpath> esophagus tissues from the control group with no esophageal abnormality (P = 0.002) </plain></SENT>
<SENT sid="11" pm="."><plain>GSTPI protein expression was generally highest in the basal layer of <z:mpath ids='MPATH_458'>normal</z:mpath> squamous esophagus epithelium and lowest in <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> cells, with Barrett's cells showing intermediate staining intensity </plain></SENT>
<SENT sid="12" pm="."><plain>Our results show that downregulation of GSTPI expression is an early event in the development of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>Loss of GSTPI expression may have an important role in the development and progression of this disease </plain></SENT>
</text></document>